Healthcare Industry News: Stereotactic
News Release - April 24, 2008
Elekta's New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a TimeATLANTA and CHICAGO, April 24 (HSMN NewsFeed) -- Elekta, a global leader in minimally invasive neurosurgery will feature its latest line of Stereotactic solutions at the 76th Annual Meeting of the American Association of Neurological Surgeons' (AANS), April 26 - May 1 in Chicago, Illinois. Highlights include Leksell Gamma Knife® Perfexion(TM) and Elekta Axesse(TM), two Stereotactic treatment solutions that are creating new possibilities for the most challenging cases.
Now in clinical use in twenty locations across North America, Leksell Gamma Knife Perfexion combines the proven precision of the revolutionary Leksell Gamma Knife, with a three hundred percent expansion in clinical reach to treat a wider range of targets faster and more efficiently than ever before. The system's unique geometric and dosimetric design simultaneously administers hundreds of beams of low-intensity radiation that converge to deliver a single, therapeutic dose of radiation with pin-point accuracy to the most difficult targets; while integrated treatment planning and delivery streamlines the radiosurgery process to treat even multiple brain lesions in a single automated procedure.
Fully optimized for neurosurgery, Elekta Axesse is ideally suited for Stereotactic radiosurgery or radiotherapy of the spine and body, providing total treatment control with proven technology that minimizes time-on-table and maximizes treatment capacity. And with volumetric 3D imaging, six-degree patient positioning, and fine-resolution beam shaping of Elekta Axesse make it a versatile, crossover treatment solution for neuro-oncology.
"Elekta is committed to supporting the neurosurgeon by providing highly refined tools that support specific clinical objectives," says Joseph K. Jachinowski, President and CEO of Elekta North America. "Technology that is perfectly aligned to the physician and the case at hand naturally results in faster treatments, increased productivity, higher profitability, and most of all, more quality time for the patient."
In addition to its latest line of radiosurgery and radiotherapy solutions as well as cases studies highlighting their clinical use, Elekta will exhibit new accessories for the world's most widely used Stereotactic product line, Leksell Stereotactic System®, and Elekta Neuromag®, the world's most advanced magnetoencephalography (MEG) system.
Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state-of-the-art tools to fight serious disease.
Elekta provides advanced clinical solutions and comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders.
Elekta's systems and solutions are used in more than 5,000 hospitals around the world. Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse(TM) for Stereotactic radiosurgery or radiotherapy of the spine and body and Elekta Synergy® for advanced intensity modulated and image guided radiation therapy, as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data.
With more than 2,500 employees globally, Elekta corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.